http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004514643-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate | 1998-10-28^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-05-20^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2004514643-A |
| titleOfInvention | Erythromycin A derivative |
| abstract | Formula 1 [Wherein, n represents an integer of 1 to 7, R 1 represents a hydrogen atom or an alkyl group, R 2 represents a quinolyl group, a pyrazinyl group, a benzimidazolyl group, a thiazolyl group, a pyridyl group, a pyrimidyl group, a purinyl group, a triazinyl group, a phenyl group or a naphthyl group; R 3 represents a hydrogen atom, an alkyl group or a cinnamyl group; R 4 is a hydrogen atom or R 4 and R 5 together form an oxo group, R 5 represents a group represented by each formula of —OCO—CH 2 —R 8 , —OCO—R 8 , —OCO—NH—R 8 , —O—R 8, or —OCO—O—R 8. , R 6 and R 7 each represent a hydrogen atom or an alkyl group. ] The erythromycin A derivative represented by or a pharmaceutically acceptable salt thereof has a strong antibacterial activity not only against erythromycin-sensitive bacteria but also against erythromycin-resistant bacteria. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003523938-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015172085-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010526045-A |
| priorityDate | 1997-10-29^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 180 of 180.